Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria

Antimicrobial Agents and Chemotherapy

Volumn 39, Issue 4, 1995, Pages 882-886

  Polis, M A ^a   Spooner, K M ^a   Baird, B F ^a   Manischewitz, J F ^a   Jaffe, H S ^a   Fisher, P E ^a   Falloon, J ^a   Davey Jr , R T ^a   Kovacs, J A ^a   Walker, R E ^a   Whitcup, S M ^a   Nussenblatt, R B ^a   Lane, H C ^a   Masur, H ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN; CIDOFOVIR; CREATININE; DIPHENHYDRAMINE; GANCICLOVIR; PARACETAMOL; PROBENECID; STAVUDINE;

ADULT; AGED; ANTIVIRAL ACTIVITY; ARTICLE; BLOOD CULTURE; CARDIOMYOPATHY; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; DOSE RESPONSE; DRUG SAFETY; ERYTHRODERMA; GLUCOSURIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE COUNT; MALE; NEPHROTOXICITY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEINURIA; URINE CULTURE; VIREMIA; VIRUS CULTURE;

EID: 0028933876     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.39.4.882     Document Type: Article

References (0)